Delivery Order SPE2DB20D3101-SPE2DB22FQVW7
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,200.86, is a delivery order for the supply of Diovan HCT 160-12.5 mg tablets. The contract has an ultimate completion date of December 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $14,745.55 delivery order contract is for the supply of Diovan HCT 160-25 mg tablets, a cardiovascular medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, which serves as a primary vehicle for providing a comprehensive...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,527.22, is for the delivery of Diovan HCT 160-25 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,053.26 firm fixed-price delivery order contract is for the supply of the medication Diovan HCT 80-12.5 mg tablets. The contract has an ultimate completion date of October 31, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $21,462.60 firm fixed-price delivery order is for the supply of Diovan HCT 320-25 mg tablets. The contract has an ultimate completion date of October 21, 2024 and is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. government awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies. The contract, valued at $30,710.12, is for the provision of Diovan HCT 160-25 mg tablets to the Defense Department's Medical Supply Chain. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,878.36 firm fixed-price contract is for the supply of Diovan HCT 160-25 mg tablets. The contract is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,760.42 firm fixed-price contract is for the delivery of Diovan HCT 320-25 mg tablets. The contract is not associated with a set-aside designation, indicating open competition. It is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,239.96 firm fixed-price delivery order is for the supply of DIOVAN HCT 160-25 MG TABLET 90S, a cardiovascular medication. The contract has an ultimate completion date of July 24, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $19,717.99, is for the delivery of Diovan HCT 160-25 mg tablets. This is a firm fixed-price delivery order contract with an ultimate completion date of October 5, 2023. The contract is not designated as a set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB22FQVW7Delivery Order
This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,459.65 delivery order contract is for the supply of Diovan HCT 160-25 mg tablets. The contract has a firm-fixed price and covers delivery through September 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable streamlined government procurement of essential pharmaceutical and medical items to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award was not designated with any set-aside requirements, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.5k | 9/23/22 |